{"id":101995,"date":"2022-07-24T03:29:50","date_gmt":"2022-07-24T03:29:50","guid":{"rendered":"http:\/\/wordpress.gurbuz.net\/?p=101995"},"modified":"2022-07-24T03:36:08","modified_gmt":"2022-07-24T03:36:08","slug":"emine-kahpedogan-ates-olmayan-yerden-duman-cikmaz-nemalaniyorsunuz-ailecek-partice","status":"publish","type":"post","link":"http:\/\/wordpress.gurbuz.net\/?p=101995","title":{"rendered":"Emine KAHPEdo\u011fan ate\u015f olmayan yerden duman \u00e7\u0131kmaz. Nemalan\u0131yorsunUZ, ailecek, partice"},"content":{"rendered":"<p><strong>Cogito, ergo sum<\/strong><br \/>\n<img src=\"https:\/\/www.tagesspiegel.de\/images\/tagesspiegel\/25483266\/2-format6001.jpg?inIsFirst=true\" alt=\"\" \/><\/p>\n<p><em>Form\u00fclde de\u011fi\u015fiklik\u2026<br \/>\nNEDEN\u2026<br \/>\nOMICRON bilmem hangi NUMARA<\/em><\/p>\n<p>&#8222;Pimavanserin<br \/>\nVon Dr. Golo Beranek -3. Mai 201612031<br \/>\nPimavanserin (ACP-103)<br \/>\nBeschreibung<\/p>\n<p>Die U.S. Food and Drug Administration (FDA) erteilte am 29.04.2016 Nuplazid\u00ae (Wirkstoff Pimavanserin) die Zulassung f\u00fcr die Behandlung von Halluzinationen und Wahnvorstellungen assoziiert mit Psychosen bei zugrunde liegender Parkinson-Erkrankung.&#8220;<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"Ry6weRnUlK\"><p><a href=\"https:\/\/apothekenwiki.com\/enzyklopaedie\/pimavanserin\/\">Pimavanserin<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8222;Pimavanserin&#8220; &#8212; ApothekenWiki\" src=\"https:\/\/apothekenwiki.com\/enzyklopaedie\/pimavanserin\/embed\/#?secret=893882ETcv#?secret=Ry6weRnUlK\" data-secret=\"Ry6weRnUlK\" width=\"525\" height=\"296\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cogito, ergo sum Form\u00fclde de\u011fi\u015fiklik\u2026 NEDEN\u2026 OMICRON bilmem hangi NUMARA &#8222;Pimavanserin Von Dr. Golo Beranek -3. Mai 201612031 Pimavanserin (ACP-103) Beschreibung Die U.S. Food and Drug Administration (FDA) erteilte am 29.04.2016 Nuplazid\u00ae (Wirkstoff Pimavanserin) die Zulassung f\u00fcr die Behandlung von Halluzinationen und Wahnvorstellungen assoziiert mit Psychosen bei zugrunde liegender Parkinson-Erkrankung.&#8220; Pimavanserin<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/posts\/101995"}],"collection":[{"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=101995"}],"version-history":[{"count":5,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/posts\/101995\/revisions"}],"predecessor-version":[{"id":102000,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=\/wp\/v2\/posts\/101995\/revisions\/102000"}],"wp:attachment":[{"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=101995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=101995"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/wordpress.gurbuz.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=101995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}